Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
8.49
+0.11 (1.31%)
At close: Feb 27, 2026, 4:00 PM EST
8.58
+0.09 (1.06%)
After-hours: Feb 27, 2026, 6:58 PM EST
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $19.85 million as of February 27, 2026. Its market cap has decreased by -42.54% in one year.
Market Cap
19.85M
Enterprise Value
15.99M
1-Year Change
-42.54%
Ranking
Category
Stock Price
$8.49
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $19.85M, a decrease of -65.88%. That is a compound annual growth rate of -29.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 19.85M | 25.22% |
| Dec 31, 2025 | 15.85M | -38.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuphoria Therapeutics | 23.02M |
| Polyrizon | 22.14M |
| NanoViricides | 21.72M |
| VYNE Therapeutics | 19.61M |
| Pasithea Therapeutics | 19.25M |
| Jupiter Neurosciences | 19.20M |
| FibroBiologics | 19.00M |
| Serina Therapeutics | 18.87M |